BlackRock Fund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$60.9M	Buy	560,812 +67,142	+14%	+$8M	0.01%	1551
2016 Q3	$81.3M	Buy	493,670 +16,562	+3%	+$2.61M	0.02%	1234
2016 Q2	$68.1M	Buy	477,108 +9,836	+2%	+$1.43M	0.02%	1291
2016 Q1	$60M	Buy	467,272 +31,289	+7%	+$3.69M	0.01%	1323
2015 Q4	$65.1M	Sell	435,983 -52,194	-11%	-$8.84M	0.02%	1287
2015 Q3	$81M	Buy	488,177 +38,162	+8%	+$8.39M	0.02%	1064
2015 Q2	$109M	Buy	450,015 +56,691	+14%	+$15.1M	0.03%	926
2015 Q1	$111M	Buy	393,324 +48,982	+14%	+$10.6M	0.03%	907
2014 Q4	$53.7M	Buy	344,342 +247,026	+254%	+$45.6M	0.01%	1415
2014 Q3	$23M	Buy	97,316 +15,346	+19%	+$3.91M	0.01%	1866
2014 Q2	$19.4M	Sell	81,970 -118,472	-59%	-$31.2M	0.01%	2040
2014 Q1	$66.1M	Buy	200,442 +5,860	+3%	+$1.98M	0.02%	1193
2013 Q4	$13.3M	Sell	194,582 -8,554	-4%	-$494K	﹤0.01%	2211
2013 Q3	$14M	Buy	203,136 +46,452	+30%	+$2.29M	﹤0.01%	2161
2013 Q2	$7.03M	Buy	+156,684	New	+$5.35M	﹤0.01%	2483